While the WHO decided not to recommend GLP-1 agonists for diabetes treatment in its 2023 Essential Medicines List (EML), it is likely that they will be recommended in the 2025 update, after an expert committee meeting in May
Start your intake Why Standard Dosing Charts Miss the Personalization Picture Published dosing charts provide a starting reference, but they cannot account for individual variation in peptide receptor expression, metabolic capacity, or body composition distribution
Arztebl Int
If you find yourself struggling with severe stomach upset, it is often best to simplify your routine
suis infected animals with these two substrates, Gln or GSH, resulted in a marked reduction of infection-related gastric pathologies, both related to inflammation and epithelial cell damage
Antioxidants and statins (3-hydroxy-3-methylglutary-coenzyme A reductase inhibitors) A three-year randomized controlled trial in 160 patients with coronary heart disease (CHD) and low high-density-lipoprotein (HDL) levels found that a combination of simvastatin (Zocor) and niacin increased the HDL2 subfraction level (considered the most cardioprotective), inhibited the progression of coronary artery stenosis (narrowing), and decreased the frequency of cardiovascular events, such as myocardial infarction and stroke (130)